SureTrader SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Biotechs >

Parexel International Corp. (PRXL)

PRXL RSS Feed
Add PRXL Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/26/2017 3:48:35 PM - Followers: 2 - Board type: Free - Posts Today: 0

Parexel International Corporation, a biopharmaceutical services company, provides clinical research, medical marketing, consulting, and informatics and advanced technology products and services to pharmaceutical, biotechnology, and medical device industries worldwide. The company operates through three segments: Clinical Research Services, PAREXEL Consulting and Medical Marketing, and Perceptive. The Clinical Research Services segment offers clinical trials management and biostatistics, data management, and clinical pharmacology, as well as related medical advisory and investigator site services. It provides these services in cardiology, oncology, infectious diseases, neurology, allergy/immunology, endocrinology/metabolism, gastroenterology, obstetrics/gynecology, orthopedics, pediatrics, psychiatry, and transplantation areas. The PAREXEL Consulting and Medical Marketing segment offers drug development, regulatory, manufacturing compliance, business process consulting, staffing solutions, and marketing expertise consultation to the pharmaceutical, biopharmaceutical, and medical device industries in the United States, Europe, and Asia. The Perceptive segment offers a portfolio of products and services that include medical imaging services, interactive voice response systems, clinical trials management systems, Web-based portals, systems integration, and patient diary applications. PAREXEL was founded by Josef H. von Rickenbach in 1983. The company is headquartered in Waltham, Massachusetts.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PRXL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PRXL News: Statement of Changes in Beneficial Ownership (4) 02/16/2017 03:22:29 PM
PRXL News: Statement of Ownership (sc 13g) 02/13/2017 04:00:59 PM
PRXL News: PAREXEL Launches ClinPhone RTSM Mobile App to Improve Supply Management and Increase Patient Safety 02/13/2017 09:00:00 AM
PRXL News: Amended Statement of Ownership (sc 13g/a) 02/10/2017 02:38:58 PM
PRXL News: Statement of Changes in Beneficial Ownership (4) 02/10/2017 12:23:02 PM
PostSubject
#12   I've owned this stock a long time and shub 01/26/17 03:48:35 PM
#11   Credit Suisse reiterated its buy rating on Parexel. ValueInvestor15 11/16/16 04:32:22 PM
#10   Hi June: shub 08/08/16 12:57:11 PM
#9   I have also have owned this ticker for junewong 08/07/16 05:15:03 PM
#8   This board is obviously moribund; but iv'e held shub 07/22/16 04:19:15 PM
#7   Well on the way... junewong 08/17/15 03:11:06 PM
#6   ~ $PRXL ~ Earnings posted, pending or coming Penny Roger$ 02/02/12 12:30:53 AM
#5   PRXL $20 PAREXEL has been mlkrborn 11/15/11 02:49:39 PM
#4   http://events.jspargo.com/asco10/public/Booth.aspx?IndexInList=1&FromPage=Exhibi surf1944 04/14/10 11:23:45 AM
#3   6:02AM PAREXEL announces that it has completed a surf1944 03/17/10 10:20:26 AM
#2   That was almost to the moon...very good! MrSparex 02/03/07 10:35:45 PM
#1   To da MOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOON!!!!!!!!!!!!!!!!!! MrSparex 07/07/06 01:50:57 AM
PostSubject